SASKATOON, Saskatchewan, Aug. 13, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has entered into a credit agreement with Canadian Imperial Bank of Commerce (“CIBC”) providing the Corporation with up to $20,500,000 of committed credit facilities (the “Credit Facilities”), plus a$10,000,000 accordion feature and a $1,000,000 Visa credit facility. The Credit Facilities will support PharmaCorp’s acquisition strategy and the expansion ...